日本批准VYVDURA参加CIDP, 首次通过家庭注射治疗稀有神经疾病。 Japan approves VYVDURA for CIDP, a first for treating the rare nerve disorder with home injections.

日本已批准VYVDURA治疗成年人使用CIDP,这是一种罕见的神经紊乱症。 Japan has approved VYVDURA for treating adults with CIDP, a rare nerve disorder. 这是CIDP的第一个新生儿FC受体阻塞器, 被批准在家每周自行注射。 It's the first neonatal Fc receptor blocker for CIDP, approved for self-administered weekly injections at home. 根据一项显示复发风险降低61%的研究,这一批准使日本成为获得三种药物迹象的第一个国家。 This approval, based on a study showing a 61% reduction in relapse risk, makes Japan the first country with access to three indications for this drug.